Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: A descriptive study of a large outpatient oncology practice database, 2000–2007

(2010) Ying Wu et al.   CLINICAL THERAPEUTICS

A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors

(2010) A. Kellum et al.   CURRENT MEDICAL RESEARCH AND OPINION

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

(2009) J. E. Ang et al.   ANNALS OF ONCOLOGY

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

(2009) Stefan Sleijfer et al.   EUROPEAN JOURNAL OF CANCER

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

(2009) Martee L. Hensley et al.   GYNECOLOGIC ONCOLOGY

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

(2009) Joan Maurel et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

(2009) James B Bussel et al.   LANCET

Management of Chemotherapy-Induced Thrombocytopenia: Current Status of Thrombopoietic Agents

(2009) Saroj Vadhan-Raj   SEMINARS IN HEMATOLOGY

Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma

(2008) J.-Y. Blay et al.   CLINICAL CANCER RESEARCH